Silvia Deaglio

44PUBLICATIONS
158CO-AUTHORS
Molecular targetsGene expression (incl. microarray and other genome-wide approaches)NanomedicineCancer diagnosisMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (44)

|Oct 02, 2026
SLV-404, an anti-RYK antibody-drug conjugate, is effective in Richter transformation patient-derived xenografts.

|Sep 15, 2026
Stratified Use of Genetic Testing in Liver Disease Improves Diagnostic Yield and Clinical Impact.

|Aug 13, 2026
Correction: Audrito et al. NAMPT Over-Expression Recapitulates the BRAF Inhibitor Resistant Phenotype Plasticity in Melanoma. Cancers 2020, 12, 3855.

|Mar 24, 2026
Functional cooperation between the B-cell receptor and NOTCH1 in regulating metabolic reprogramming in chronic lymphocytic leukemia.

Amelia Fascì, Francesco Edoardo Vallone, Nahal Nabelsi

|Jan 28, 2026
Antibody-Drug Conjugates in Hematological Malignancies: Current Landscape and Future Perspectives.

Maria Chiara Montalbano, Matilde Micillo, Silvia Deaglio

|Nov 27, 2025
Functional Characterization of a Novel PBX1 De Novo Missense Variant Identified in a Pediatric Patient with CAKUT.

Caterina Scolari, Angelo Corso Faini, Giulia Verra

Pageof 8

Frequent Collaborators

12 joint publications

Tiziana Vaisitti

5 joint publications

Arianna Di Napoli

4 joint publications

Chiara Riganti

4 joint publications

Valentina Audrito